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Abstract
Background: The Pediatric Quality of Life Inventory (PedsQL) is widely used instrument to measure pediatric
health-related quality of life (HRQOL) for children aged 2 to 18 years. The purpose of the current study was to
investigate the feasibility, reliability and validity of the Chinese mandarin version of the PedsQL 4.0 Generic Core
Scales and 3.0 Cancer Module in a group of Chinese children with cancer.
Methods: The PedsQL 4.0 Genetic Core Scales and the PedsQL 3.0 Cancer Module were administered to children
with cancer (aged 5-18 years) and parents of such children (aged 2-18 years). For comparison, a survey on a
demographically group-matched sample of the general population with children (aged 5-18) and parents of
children (aged 2-18 years) was conducted with the PedsQL 4.0 Genetic Core Scales.
Result: The minimal mean percentage of missing item responses (except the School Functioning scale) supported
the feasibility of the PedsQL 4.0 Generic Core Scales and 3.0 Cancer Module for Chinese children with cancer. Most
of the scales showed satisfactory reliability with Cronbach’s a of exceeding 0.70, and all scales demonstrated
sufficient test-retest reliability. Assessing the clinical validity of the questionnaires, statistically significant difference
was found between healthy children and children with cancer, and between children on-treatment versus off-
treatment ≥12 months. Positive significant correlations were observed between the scores of the PedsQL 4.0
Generic Core Scale and the PedsQL 3.0 Cancer Module. Exploratory factor analysis demonstrated sufficient factorial
validity. Moderate to good agreement was found between child self- and parent proxy-reports.
Conclusion: The findings support the feasibility, reliability and validity of the Chinese Mandarin version of PedsQL
4.0 Generic Core Scales and 3.0 Cancer Module in children with cancer living in mainland China.
Background
Currently, an increasing number of children with cancer
are cured for their diseases in the world, including
China. However, common treatments such as surgery,
radiotherapy, chemotherapy, whether palliative or cura-
tive, can have deleterious side-effects affecting many
aspect of the quality of children’sl i v e s– not only
physical aspects but also social and emotional aspects
[1,2]. Survivors may experience a number of long-term
adverse effects from the tumor and its treatment [3-6].
Focusing on the patients’ psychosocial and social well-
being in addition to their physical health is an essential
requirement in accordance with the WHO definition of
health and well-being [7].
Health-related quality of life (HRQOL) is a continuous
concept influenced by a person’s objective assessments
of function or health status as well as subjective percep-
tions of their personal health [8]. It is increasingly
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in clinical trials and health services research and evalua-
tion. However, one challenge in measuring HRQOL in
children is that the instrument must account for the
continuous physical, emotional, social and cognitive
development during childhood and adolescence.
Another problem is the questionnaires should provide
the required information [9]. Although there are a num-
ber of generic HRQOL instruments applicable to chil-
dren, assessment has relied exclusively on proxy-report
[10], or the concordance between self- and proxy-report
has been demonstrated to be imperfect [11]. Given the
multidimensional impact cancer has on children, it is
necessary to find an appropriate instrument to capture
and evaluate the HRQOL of these children.
The Pediatric Quality of Life Inventory (PedsQL) is
one of the more promising HRQOL measures for chil-
dren aged 2-18 years [12,13]. The advantages of PedsQL
included brevity, availability of age-appropriate version,
and parallel for child and parent. The approach is mod-
ular, with Generic Core Scales complemented by dis-
ease-specific modules, such as the PedsQL Cancer
Module [14-19]. The PedsQL 4.0 Generic Core Scales
was specifically designed for application in both healthy
and patient populations. The PedsQL 3.0 Cancer Mod-
ule was designed to measure HRQOL dimensions speci-
fic to pediatric cancers. Studies with PedsQL indicate
that both healthy children and children with cancer
aged 5-18 years can self-report their HRQOL [20-22].
As the population of Chinese children nears 300 mil-
lion, a conservative projection of 45 thousands new
cases of pediatric cancer each year can be made [23].
However, limited information is available to understand
the HRQOL of children with cancer living in mainland
China. The objective of this study was to investigate the
feasibility, reliability, and validity of the Chinese man-
darin version of the PedsQL 4.0 Generic Core Scales
and 3.0 Cancer Module in children with cancer.
Method
Participants and Settings
This study was developed in the cities of Shanghai and
Chongqing, China. We recruited children with cancer
and their parents by means of convenience samples
from 2 children’s hospitals at the cities. Children aged 5
to 18 years who were diagnosed with cancer were
included in this study, and the parents were included if
their child was 2 to 18 years old. Children were
excluded from this study if they had comorbid disease
or major developmental disorders. The sample size
needed to procedure medium correlation (0.30) in the
examination of discriminant validity was calculated. 154
subjects were needed to take part in the study when we
set the type Ⅰ error at 1% and the statistical power at
90%. We estimated that approximately more than 60-
70% of participants would agree to participate. Finally,
two hundred and seventy five families were approached
for the study. Controls were 300 families of healthy chil-
dren aged 2 to 18 years recruited from schools, with dis-
tributional matching to the patients on age and gender.
Measurement
PedsQL 4.0 Generic Core Scales
The 23-item PedsQL 4.0 Generic Core Scales encom-
passes the essential core domains for pediatric HRQOL
measurement: (1) physical functioning (8 items), (2)
emotional functioning (5 items), (3) social functioning
(5 items), and (4) school functioning (5 items). It com-
prises of parallel child self-report and parent proxy-
report format. Child self-report includes ages 5-7 (young
children), 8-12 (children), and 13-18 (teens) years.
Patent proxy-report includes ages 2-4 (toddlers), 5-7, 8-
12, and 13-18 years. The items for each of the forms are
essentially identical, differing in developmentally appro-
priate language, or first or third person tense. The
instructions ask how much of a problem each item has
been during the past one month. A 5-point response
scale is utilized across child self-report for ages 8-18
and parent proxy-report (0 = never a problem; 1 =
almost never a problem; 2 = sometimes a problem; 3 =
often a problem; 4 = almost always a problem). The
child-report for children aged 5-7 is completed with the
help of an interviewer. To increase its ease of use, the
rating scale has been reworded and simplified to a 3-
p o i n ts c a l e( 0=n o ta ta l lap r o b l e m ;2=s o m e t i m e sa
problem; 4 = a lot of a problem), with each response
choice anchored to a happy to sad faces scale. Items are
reverse-scored and linearly transformed to a 0-100 scale,
with higher scores indicating a better HRQOL. Scale
scores are computed as the sum of the items divided by
the number of items answered. If more than 50% of the
items in the scale are missing, the scale score is not
computed. To create the Psychosocial Functioning
score, the mean is computed as the sum of the items
divided by the number of the items answered in the
Emotional, Social, and School Functioning Scale.
PedsQL 3.0 Cancer Module
The PedsQL 3.0 Cancer Module instrument encom-
passes 8 subscales: (1) pain and hurt (2 items), (2) nau-
sea (5 items), (3) procedural anxiety (3 items), (4)
treatment anxiety (3 items), (5) worry (3 items), (6) cog-
nitive problems (5 items), (7) perceived physical appear-
ance (3 items), and (8) communication (3 items). The
cognitive problems scales were modified to include
fewer items for children aged 2-7 years. The format,
instructions, Likert response scale, and scoring method
of the Cancer Module are identical to the PedsQL 4.0
Generic Core Scales [24].
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The investigation was performed by 4 research students
majoring in Pediatrics and 2 nurses. All of them were
trained in interviewing and administering question-
naires. On-treatment status was defined as patients who
were receiving medical treatment to induce remission.
Off-treatment status was defined as patients who com-
pleted all therapy by the time of the assessment [25,26].
The on-treatment patient was interviewed while hospita-
lized. The off-treatment patient was interviewed during
clinic visits. Parents were interviewed first, and were
asked whether they would allow their children to parti-
cipate in the study. The parents and their children com-
pleted the questionnaire independently during the
pediatric patients’ hospitalization or outpatient depart-
ment visit. All the parents were asked to fill out the
PedsQL 4.0 Generic Core Scales and the Cancer Mod-
ule. The children were required to complete the ques-
tionnaires by self-administration except the Young
Children by interview-administration [19]. The inter-
viewers were available to assist the completion of the
questionnaires if the parents/children had questions on
semantic or conceptual understanding. They were also
responsible for collecting and checking the question-
naires to ensure that there were no missing data or logi-
cal mistakes. Test-retest reliability was assessed at
Children’s Hospital of Fudan University (the same hos-
pital in Shanghai). Thirty-four families with patients in
stable condition according to their physician completed
the PedsQL measures a second time (with an interval of
1-3 weeks between applications). For control group, the
questionnaires interviews were conducted at schools.
Written information was sent to parents who completed
questionnaires at home, returning them to school by a
specified date.
Cross-culture adaptation and Ethical considerations
The Chinese Mandarin Version was provided by MAPI
Research Trust that translated the version according to
their standardized procedures. Briefly, the instruments
were translated independently into Chinese by two pro-
fessional translators (native Chinese speakers) and trans-
lated back into English by two English native speakers
(bilingual in Chinese). Then, a comparison between the
backward version and the original version was assessed
in order to detect any misunderstandings or mistransla-
tions in the intermediary forward version of the ques-
tionnaires [27,28]. 15 children with cancer participated
in pilot testing along with their parents. In consideration
of the Chinese sociocultural environment, we avoided
using the term ‘cancer’ or ‘tumor’ in questionnaires. The
permission was obtained from its developer, James W.
Varni, PhD. The human subject institutional review
boards at each hospital approved the study. All subjects
were given detailed written information about the meth-
ods, aims, and the voluntary nature of participation in
the study, and written parental informed consent and
child assent were obtained prior to enrollment.
Statistical analysis
Feasibility was determined from the average completion
time and percentage of missing response. The average
completion time was defined as the mean of completion
time of the Generic Core Scales and Cancer Module.
The percentage of all possible item-responses left unan-
swered was calculated for each subject on each single
and summary scale and averaged over subjects [29]. The
presence of floor and ceiling effects was assessed for the
subscales scores and summary scores.
Scale internal consistency reliability was determined
by calculating Cronbach’s coefficient alpha. Scales with
reliabilities of 0.70 or greater are recommended for
comparing patients groups, while a reliability criterion
of 0.90 is recommended for analyzing individual patient
scale scores [30]. To determine retest reliability, the
intra-class correlation coefficients (ICCs) between the
initial test and retest scores was examined, with an ICC
value of 0.40 representing moderate, 0.60 good, and 0.80
high agreement [31].
Discriminant validity was determined using the
known-groups method. The Generic Core Scales scores
were compared between groups differing in known
health conditions (healthy children and children with
cancer). HRQOL scores of children from the general
population and children with cancer were compared
using independent sample t test. To determine the mag-
nitude of the differences, effect sizes were evaluated.
Effect size as utilized in these analyses was calculated by
taking the difference between the healthy sample mean
and the oncology sample mean, divided by the pooled
standard deviation [32]. Additionally, analyses of var-
iance also were conducted to examine whether there
were differences in Generic Core Scales and Cancer
Module scores among children with cancer on treat-
ment and off-treatment (≤ 12 months or > 12 months).
We hypothesized that healthy children would have
higher PedsQL 4.0 scores (better HRQOL) than children
with cancer. Moreover, we hypothesized that children
with cancer on-treatment would report significant differ-
ences in HRQOL compared with those of children with
cancer off-treatment based on previous studies
[19,33,34].
Construct validity for the Cancer Module was exam-
ined through an analysis between the Cancer Module
Scales scores and relevant Generic Core Scales scores. It
had been reported that computing the intercorrelations
a m o n gs c a l e sp r o v i d e si n i t i a li n f o r m a t i o no nt h ec o n -
struct validity of an instrument. We hypothesized
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correlate with lower overall generic HRQOL based on
the conceptualization of disease-specific symptoms as
causal indicators of generic HRQOL [35]. Correlation
effect sizes were designed as small (0.01-0.29), medium
(0.30-0.49), and large (≥ 0.50). Pearson coefficients were
utilized in these analyses.
Exploratory factor analysis was performed on the
items to test the PedsQL underlying dimensions [36].
Principal component analysis with oblique rotation was
performed to extract the factors. Factors with an eigen-
value less than 1.0 were disregarded.
Parent/child intercorrelations were computed to
examine cross-informant variance [37]. Correlation
effect sizes are designated as small (0.01-0.29), medium
(0.30-0.49), and large (≥ 0.50).
Statistical analyses of the study were conducted by
SPSS 16.0 for Window (SPSS, Inc, Chicago, USA) and
the significance level was set at 0.05.
Results
Sample characteristics
Of the patients group, 7 families refused to participate
due to non-compliance, 2 children were later found to
be ineligible and excluded from analysis, leaving 266 eli-
gible families. The patients group was comprised of 202
children aged 5-18 years and 266 parents of children
aged 2-18 years. The mean age of the 154 boys (57.9%)
and 112 girls (42.1%) was 8.8 years (SD = 3.8). One hun-
dred sixty-three patients (61.3%) had been diagnosed
with hematological diseases, and the remaining patients
(38.7%) had solid tumors. The mother answered the
questionnaires in 82.7% of the cases and the father in
17.3% of the cases. 109 (41.0%) patients completed all
therapy by the time of assessment (n = 109), and 74
(27.8%) patients had been off treatment for over 12
months (n = 74). Of the control group, 284 families
returned the questionnaires, which gave a response rate
of 94.7%. The mean age of the 159 boys (56.0%) and
125 girls (44.0%) was 9.1 years (SD = 3.9). Self-report
forms are completed by 216 children (Table 1). There
was no statistically significant difference between
patients and healthy children refer to age and gender.
Descriptive statistics
As showed in Table 2 the Generic Core scores were
consistently higher for child reports than for parent
reports. No floor effects were seen in the patient group.
We found ceiling effects both in child self- and parent
proxy-reports ranging from 2.6% to 19.8% in the patient
group and 5.6 to 39.8% in the control group, with high-
est values in the Social Functioning Scale for child self-
and parent proxy-reports from the patient and compari-
son samples. We also observed greater ceiling (18.0-
40.6%) than floor effects (0.8-5.6%) in the Cancer Mod-
ule, with a notable ceiling effect in the Pain and hurt
scale and a moderate one in other scales for child self-
and parent proxy-reports (Table 3).
Feasibility
The majority of patients and their parents needed only
10-18 and 6-10 minutes to complete the two question-
naires, respectively. For child self- and parent proxy-
report on the PedsQL 4.0 Generic Core Scales, the per-
centage of missing item responses was 0.6% and 0.4%,
respectively, for all scales except the School Functioning
Scale. The percentage of missing items for the School
Functioning scale was 21.5% for child self-report (aged
5-18 years) and 46.3% for parent proxy-report (aged 2-
18 years). This large percentage missing items for the
School Functioning scale may exist because many Chi-
nese children younger than 7 years neither attend kin-
dergarten nor school. For child self- and parent proxy-
report on the PedsQL 3.0 Cancer Module, the percen-
tage of missing item responses was 0.9% and 1.3%,
respectively, for all scales. On this module, 40.7% of the
items across all forms had no missing responses. The
highest percentage of missing responses for any single
item on the Caner Module was 3.2% for Child self-
report in the Communication Ⅱ scale (it is had for me
to ask the doctors and nurses questions) and 5.9% for
parent proxy-report in the WorryⅠ s c a l e( w o r r ya b o u t
side effect from medical treatment).
Internal consistency and test-retest reliability
Internal consistency reliability coefficients are presented
in Table 4. Cronbach’s alpha for Total Scale of the Gen-
eric Scales and the Caner Scale were all above 0.7 in
both self- and proxy-reports. Most scales exceeded the
minimum reliability standard of 0.70, and a number of
scales approached or met the reliability criterion of 0.90
recommended for analyzing individual patient scores.
Retests for reliability were completed by 27 children
with cancer (aged 5-18 years) and 34 patents of such
children (aged 2-18 years) who completed the initial
questionnaires. ICCs for test-retest reliability for child
self- and parent proxy-report are presented in Table 4.
All of these ICCs are in the good to excellent reliability
range.
Validity
Table 2 demonstrates the differences between healthy
children and children with cancer. For each Generic
Core Scale, children with cancer and their parents
report statistically significant lower HRQOL than
healthy children. Table 5 provides the result comparing
the three groups of patients in known distinct clinical
conditions (on-treatment, off treatment ≤ 12 months
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e n tp r o x y - r e p o r to nt h eP e d s Q LG e n e r i cC o r eS c a l e s
and Cancer Module. For both child self- and parent
proxy-report, the PedsQL 4.0 Generic Core Scale Total
Score, Physical Functioning, and Emotional Functioning
scores demonstrated significant differences between the
patients on-treatment and off-treatment > 12 months.
For the PedsQL 3.0 Caner Module Scales, children who
had been off-treatment over 12 months and their par-
ents demonstrated significant higher scores than chil-
dren who had been on-treatment on the Pain and hurt,
Nausea, and Procedural Anxiety subscales. In addition,
Table 1 Characteristics of the patients with cancer and healthy children




12 m (n = 35)
Child off-treatment >





n % n% n% n % n %
Age
2-4 47 29.9 9 25.7 8 10.8 64 24.1 68 23.9
5-7 42 26.8 10 28.6 25 33.8 77 28.9 81 28.5
8-12 38 24.2 8 22.9 23 31.1 69 25.9 74 26.1
13-18 30 19.1 8 22.9 18 24.3 56 21.1 61 21.5
Gender†
Male 92 58.6 20 57.1 42 56.8 154 57.9 159 56.0
Female 65 41.4 15 42.9 32 43.2 112 42.1 125 44.0
Diagnosis
Leukemia or lymphoma 91 58.0 22 62.9 50 67.6 163 61.3 -
Solid tumor 66 42.0 13 37.1 24 32.4 103 38.7 -
Education
Non-attendance 50 31.8 9 25.7 12 16.2 71 26.7 0 0.0
Current school attendance 107 68.2 26 74.3 62 83.8 195 73.3 284 100.0
Parents
Mother 131 83.4 27 77.1 62 83.8 220 82.7 237 83.5
Father 26 16.6 8 22.9 12 16.2 46 17.3 47 16.5
n: number of individuals.
Table 2 Scale descriptives for PedsQL 4.0 Generic Core Scales child self- and parent proxy-report, and comparisons
between children with cancer and healthy children scores
Scale Children with cancer Healthy children Effect size* t†
n Mean (SD) %Floor/%Ceiling n Mean (SD) %Floor/%Ceiling
Child Self-report
Total score 202 68.56 (17.4) 0.00/4.0 216 84.72 (16.4) 0.00/6.5 0.96 9.77
Physical functioning 202 67.96 (19.9) 0.00/11.4 216 86.33 (16.1) 0.00/18.5 1.03 10.39
Psychosocial functioning 202 69.20 (18.4) 0.00/5.1 216 84.20 (17.3) 0.00/16.2 0.86 8.59
Emotional functioning 202 68.40 (20.9) 0.00/12.9 215 80.25 (15.8) 0.00/37.2 0.68 6.57
Social functioning 202 78.31 (16.1) 0.00/19.8 216 88.16 (17.6) 0.00/39.8 0.57 5.95
School functioning 165 62.19 (22.5) 0.00/8.5 213 83.81 (16.2) 0.00/31.9 1.15 10.87
Parent Proxy-report
Total score 266 65.54 (18.8) 0.00/2.6 284 80.74 (16.9) 0.00/5.6 0.87 9.81
Physical functioning 266 66.13 (20.5) 0.38/10.9 284 82.18 (17.6) 0.00/15.8 0.92 9.88
Psychosocial functioning 266 65.06 (18.7) 0.00/4.2 284 80.09 (17.6) 0.00/15.1 0.84 9.69
Emotional functioning 266 64.07 (19.5) 0.00/11.3 284 76.90 (16.6) 0.00/33.8 0.73 8.32
Social functioning 266 73.49 (17.6) 0.00/18.8 284 85.33 (15.4) 0.00/38.0 0.70 8.42
School functioning 195 60.55 (23.6) 0.00/6.7 284 78.03 (16.5) 0.00/29.9 0.87 9.54
SD: standard deviation.
*Effect size for differences in means are designated as small (0.20-0.49), medium (0.50-0.79), and large (0.80 and above) in magnitude.
†All scale scores for the children with caner are significant differences from healthy children (p < .0.01) based on the independent sample t test.
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Scale Child self-reports Parent proxy-reports
n Mean (SD) %Floor/%Ceiling n Mean (SD) %Floor/%Ceiling
Pain and hurt 202 74.24 (21.89) 1.0/40.6 266 77.41 (20.72) 0.8/38.0
Nausea 202 75.73 (20.54) 1.5/37.1 266 73.21 (19.45) 1.9/33.8
Procedural anxiety 202 68.02 (27.34) 4.5/28.2 266 64.14 (24.73) 5.6/20.8
Treatment anxiety 202 71.68 (24.24) 4.0/26.7 266 67.13 (23.69) 3.0/20.1
Worry 201 68.14 (25.19) 3.0/31.6 262 62.92 (24.30) 1.9/23.2
Cognitive problems 200 71.72 (29.33) 3.0/18.5 260 73.93 (26.60) 1.2/18.0
Perceived physical appearance 202 76.35 (20.47) 3.5/33.8 261 77.91 (17.21) 0.8/28.0
Communication 201 72.19 (20.19) 1.5/24.7 262 71.63 (23.61) 1.5/25.0
Table 4 Reliability of the Chinese mandarin version of the PedsQL 4.0 Generic Core Scales and 3.0 Cancer Module:
self- and proxy-reports
Scale Internal consistency reliability Retest reliability
2-4 years 5-7 years 8-12 years 13-18 years Total
n a n a n a n a n a ICC
Generic Scale
Total score NA 77 0.82 69 0.85 56 0.89 202 0.86 0.81
64 0.87 77 0.90 69 0.92 56 0.91 266 0.91 0.83
Physical functioning NA 77 0.65 69 0.83 56 0.82 202 0.81 0.90
64 0.84 77 0.88 69 0.85 56 0.86 266 0.84 0.89
Psychosocial functioning NA 77 0.72 69 0.84 56 0.81 202 0.82 0.79
64 0.85 77 0.87 69 0.88 56 0.87 266 0.86 0.78
Emotional functioning NA 77 0.68 69 0.78 56 0.76 202 0.73 0.74
64 0.72 77 0.73 69 0.76 56 0.80 266 0.79 0.77
Social functioning NA 77 0.56 69 0.68 56 0.79 202 0.71 0.71
64 0.76 77 0.82 69 0.79 56 0.83 266 0.80 0.75
School functioning NA 49 0.47 64 0.66 55 0.69 165 0.65 0.78
27 0.68 49 0.75 64 0.72 55 0.71 195 0.72 0.84
Cancer scale
Total scale NA 77 0.70 69 0.79 56 0.81 202 0.77 0.76
64 0.83 77 0.85 69 0.87 56 0.88 266 0.87 0.84
Pain and hurt NA 77 0.66 69 0.70 56 0.72 202 0.69 0.61
64 0.80 77 0.83 69 0.87 56 0.90 266 0.88 0.75
Nausea NA 77 0.78 69 0.80 56 0.85 202 0.81 0.63
64 0.83 77 0.83 69 0.88 56 0.86 266 0.85 0.79
Procedural anxiety NA 77 0.74 69 0.82 56 0.84 202 0.76 0.77
64 0.85 77 0.86 69 0.89 56 0.88 266 0.89 0.73
Treatment anxiety NA 77 0.75 59 0.81 56 0.83 202 0.78 0.75
64 0.88 77 0.87 59 0.87 56 0.89 266 0.88 0.61
Worry NA 76 0.55 59 0.76 56 0.81 201 0.75 0.82
61 0.90 76 0.86 59 0.85 56 0.88 262 0.87 0.79
Cognitive problems NA 75 0.50 59 0.70 56 0.74 200 0.74 0.68
59 0.71 76 0.79 59 0.78 56 0.87 260 0.80 0.80
Perceived physical appearance NA 77 0.54 59 0.65 56 0.71 201 0.61 0.74
60 0.62 76 0.71 59 0.74 56 0.80 261 0.75 0.80
Communication NA 76 0.62 59 0.70 56 0.73 202 0.69 0.72
60 0.87 77 0.82 59 0.84 56 0.81 262 0.84 0.70
Reliability of parent proxy-report is set in boldface.
NA: not applicable; a: Cronbach’s coefficient alpha; ICC: intraclass correlation coefficient.
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and Worry subscale were significant differences between
children on-treatment versus off-treatment > 12 months.
The result of the factor analysis for child self- and parent
proxy-report of the Generic Core Scales and Cancer Mod-
ule are presented in Table 6 and 7. For the Generic Core
Scales, an eigenvalue cutoff of 1.0 resulted in a six factor
solution for child self- and parent proxy-report, account-
ing for 62.3% and 69.6% of the variance, respectively. For
the Cancer Module, an eight factor solution for child self-
report was result, accounting for 78.0% of the variance;
and a seven-factor solution for parent proxy-report was
result, accounting for 86.6% of the variance.
As to the intercorrelations among the various Generic
Core Scales and the Cancer Module scales estimated
using correlation coefficients. As anticipated, correlation
coefficients between the Generic Core Scale Total Scale
and the Cancer Module subscales were of medium to
large effect size for both the child self- and parent
proxy-reports (Table 8).
Table 8 presents the correlation between scores of the
child self- and parent proxy-reports of the Genetic Core
Scales and the Caner Module. A positive correlation
between child self- and parent proxy-reports was found
on all scales of both the Generic Core Scales and the
Cancer Module.
Discussion
This study demonstrated the feasibility, reliability, and
validity of the Chinese mandarin version of PedsQL 4.0
Generic Core Scales and 3.0 Cancer Module in children
with cancer living in mainland China.
Table 5 One-way ANOVA comparing HRQOL (generic scale and cancer scale) between children on- and off-treatment
(≤ 12 months or > 12 months): self- and proxy-report (bold)
Scales Child On-treatment (a) Child off-treatment (b) Child off-treatment (c) Difference F P
≤ 12 months > 12 months Value
n mean (SD) n Mean (SD) n Mean (SD)
Generic Scale
Total score 110 65.42 (16.98) 26 67.14 (18.05) 66 73.69 (16.19) a < c** 5.04 0.007
157 62.33 (16.70) 35 65.92 (19.43) 74 71.22 (17.92) a < c*** 6.58 0.002
Physical functioning 110 62.57 (21.08) 26 67.12 (18.25) 66 76.26 (19.24) a < c***, b < c* 9.53 0.000
157 61.55 (18.67) 35 66.18 (20.63) 74 75.51 (21.15) a < c***, b < c* 12.7 0.000
Psychosocial functioning 110 67.94 (17.53) 26 67.23 (19.77) 66 72.20 (18.92) 1.30 0.275
157 63.07 (19.40) 35 66.04 (17.36) 74 68.87 (18.56) 2.42 0.091
Emotional functioning 110 64.71 (19.54) 26 67.36 (22.81) 66 73.64 (20.16) a < c** 4.05 0.019
157 59.82 (24.58) 35 68.40 (21.82) 74 70.71 (18.44) a < b*, a < c*** 6.44 0.002
Social functioning 110 77.97 (17.48) 26 75.03 (18.24) 66 79.30 (15.68) 0.59 0.556
157 72.02 (20.68) 35 72.26 (18.52) 74 75.16 (18.79) 0.65 0.524
School functioning 86 58.47 (19.89) 20 60.35 (18.55) 59 65.18 (23.09) 1.81 0.167
107 57.96 (19.30) 26 60.80 (22.25) 62 62.94 (24.35) 1.08 0.342
Cancer scale
Pain and hurt 110 70.23 (20.54) 26 75.35 (20.19) 66 78.66 (22.47) a < c* 3.38 0.036
157 74.68 (19.03) 35 77.81 (21.45) 74 82.12 (20.60) a < c** 3.57 0.029
Nausea 110 63.92 (22.36) 26 78.72 (19.11) 66 83.20 (18.59) a < b**, a < c*** 19.22 0.000
157 66.81 (18.29) 35 72.34 (23.05) 74 81.72 (16.14) a < c***, b < c* 16.5 0.000
Procedural anxiety 110 63.17 (28.31) 26 70.29(25.25) 66 73.33 (24.90) a < c* 3.12 0.046
157 62.42 (22.63) 35 64.71 (25.39) 74 76.26 (24.87) a < c***, b < c* 8.74 0.000
Treatment anxiety 110 68.77 (23.48) 26 72.11 (26.23) 66 73.84 (20.64) 1.05 0.352
157 62.85 (20.69) 35 68.05 (24.38) 74 72.97 (23.38) a < c** 5.46 0.005
Worry 110 66.59 (23.24) 26 70.33 (28.10) 66 71.32 (25.61) 0.83 0.438
155 59.13 (22.00) 35 60.78 (24.43) 72 67.20 (24.74) a < c* 3.06 0.049
Cognitive problems 108 70.09 (25.65) 26 73.83 (30.02) 66 71.75 (29.45) 0.22 0.804
154 72.11 (23.96) 34 74.44 (29.12) 72 74.25 (26.92) 0.23 0.791
Perceived physical appearance 110 74.85 (19.48) 26 76.98 (22.17) 66 79.65 (18.34) 1.24 0.291
154 77.21 (16.90) 34 74.93 (20.55) 73 75.77 (17.49) 0.32 0.723
Communication 110 72.66 (19.11) 26 73.27 (18.40) 65 70.98 (22.75) 0.18 0.832
155 71.18 (22.83) 35 75.29 (24.52) 72 72.04 (22.38) 0.46 0.633
*P < 0.05, **P < 0.01, ***P < 0.001 based on Tukey Honestly Significantly Different post hoc analysis.
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Page 7 of 13Table 6 PedsQL 4.0 Generic Core Scales factor loadings for child self- and parent proxy-report in children with cancer
Subscale Item Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6
Physical functioning P1 .666 .000 .153 .065 .131 .126
.338 .700 .078 .041 .064 .005
P2 .825 -.037 .127 .101 -.021 .123
-.031 .779 .250 .092 .121 .243
P3 .828 .047 -.029 -.135 .100 -.022
-.020 .756 -.093 .168 .025 .042
P4 .804 .274 -.052 -.249 .004 .036
-.123 .807 -.116 .157 .210 .062
P5 .721 .468 .091 .241 -.024 -.034
.185 .693 .153 -.046 .190 .151
P6 .373 -.002 .203 .477 .094 .051
-.043 .658 .292 .082 .256 .074
P7 .620 .139 -.103 .172 .023 .072
.620 .345 .055 -.189 .028 .186
P8 .527 .228 .059 .121 .114 -.157
.571 .073 .108 .183 .259 .068
Emotional functioning E1 -.018 .070 .830 .165 .082 .130
-.049 .225 -.129 .048 .777 .009
E2 .026 .188 .710 .026 .102 .035
.093 .225 -.021 .179 .780 -.163
E3 .136 .217 .688 .105 .135 .121
.225 .182 .012 .007 .748 .134
E4 -.005 .002 .263 -.013 .071 .755
.205 .148 .050 .726 .377 -.070
E5 .173 -.206 .305 -.048 -.084 .638
.200 .143 -.082 .555 .407 -.268
Social functioning S1 .227 .697 .209 .179 -.302 .199
.202 .152 .700 .293 -.158 -.128
S2 .160 .848 .005 .009 .069 .178
-.026 -.017 .367 .777 .058 .124
S3 -.025 .695 .217 .126 .216 -.271
-.155 .040 .563 .217 .232 .176
S4 .199 .412 .781 .256 -.064 .009
-.203 .039 .506 .089 .268 .074
S5 .025 .668 .265 .318 .198 .131
.017 .254 .756 .092 .044 .003
School functioning Sc1 -.207 .378 .006 .716 -.059 .069
.161 .078 .134 -.102 .138 .664
Sc2 -.038 .031 .255 .802 .021 -.170
-.040 -.014 .187 .189 .039 .521
Sc3 -.068 .187 .089 .600 .194 .072
.179 .041 .181 .052 .047 .833
Sc4 .154 .096 .021 .040 .923 -.094
.860 .135 -.045 .181 -.012 .290
Sc5 .030 .044 .253 .095 .908 .152
.111 .233 .015 -.119 .110 .813
Eigenvalue 6.744 2.844 2.208 1.878 1.579 1.145
7.457 3.554 2.453 1.956 1.699 1.182
Percent Variance 25.32 10.364 9.602 7.164 5.865 3.977
28.074 11.103 10.665 8.071 6.517 5.138
Note: Bold values indicate the largest factor loading for each item.
In each cell, child self-report loading are shown above and the parent proxy-report loading are shown below in italics.
Extraction Method: Principle Component Analysis. Rotation Method: Oblimin with Kaiser Normalization. Total Variance Explained for child self-report: 62.3%; for
Parent Proxy-report: 69.6%.
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Page 8 of 13Table 7 PedsQL 3.0 Cancer Module factor loadings for child self- and parent proxy-report in children with cancer
Subscale Item Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6 Factor 7 Factor 8
Pain and hurt P1 .034 .104 .008 .023 .689 .150 .071 .104
-.009 .023 .029 -.16 .066 .009 .533
P2 .136 .206 .072 .049 .714 -.171 .031 .073
.097 .075 .017 .180 .091 .056 .789
Nausea N1 .854 .115 .121 .039 -.06 -.173 -.123 .219
.158 .835 -.057 .087 -.086 -.079 .016
N2 .657 .028 -.094 .044 .253 .005 .007 .130
.004 .573 .080 -.038 .021 .022 -.046
N3 .789 .018 .082 -.009 .107 -.094 -.02 -.007
.199 .827 -.013 .156 -.057 .069 .134
N4 .668 -.183 .038 .019 .032 .111 -.04 -.072
.052 .731 -.123 .070 .075 .147 .343
N5 .821 -.008 .145 .114 .049 .138 -.077 -.033
.190 .727 .089 .026 .244 .080 .093
Procedural anxiety PA1 .011 .159 .042 .866 .061 .103 -.133 .199
.766 -.114 .043 -.061 .070 -.047 .184
PA2 .050 .043 -.03 .876 .055 -.100 .035 -.08
.860 .156 .030 -.022 -.156 .070 .361
PA3 -.057 .137 .212 .917 .011 -.069 .099 .061
.848 .035 -.044 -.095 -.007 .062 .005
Treatment anxiety TA1 .350 .840 .040 .158 .135 .009 .133 -.1
.821 .024 .085 .248 .114 .105 .045
TA2 .071 .795 .127 .030 .135 .069 .193 -.068
.864 .290 .092 .096 .210 .157 -.082
TA3 .156 .861 .011 .186 .293 -.101 -.021 -.035
.888 .155 .116 .245 .046 .041 -.099
Worry W1 .049 .013 .622 -.011 .127 .028 .049 -.095
.033 .043 .118 .561 .040 .060 .063
W2 .253 .172 .751 .176 .033 .044 .083 .003
.021 .024 .014 .775 .142 -.022 .191
W3 .066 .021 .807 .125 .004 .058 .062 .201
-.054 .099 .078 .775 .020 .184 .004
Cognitive problems CP1 -.197 -.03 .012 .120 .031 .882 .105 .038
.196 .137 .849 -.051 .273 .087 .163
CP2 .004 -.165 -.04 -.034 -.083 .863 .079 .138
.112 .051 .9 .034 .070 .219 .073
CP3 -.137 -.041 -.198 .011 .391 .631 .120 -.009
-.013 -.004 .614 .191 .243 .091 .172
CP4 -.002 .221 .006 -.119 .085 .706 .098 .109
.223 -.044 .742 .002 .180 .279 -.057
CP5 -.204 .134 -.109 -.073 .177 .665 .074 -.022
.061 .085 .794 .155 .176 -.053 -.16
Perceived physical appearance A1 .005 .820 -.14 .050 -.087 -.024 -.192 .076
.041 .161 .246 .088 .112 .767 .270
A2 .024 .757 .046 .050 -.215 -.073 -.094 .013
.060 -.094 -.162 .179 .212 .637 -.062
A3 .213 .857 .166 -.198 -.18 .036 .033 -.047
-.079 -.106 .030 .142 .079 .666 -.03
Communication C1 .123 .101 .182 .118 .159 .020 .060 .611
.009 .131 .074 .044 .843 .311 -.016
C2 -.083 -.107 .078 .040 .148 .1 -.041 .905
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Page 9 of 13With regard to obtention of result, only a short
amount of time was required to complete the question-
naires. This short completion time made these two
instruments particularly applicable to the fast-pace set-
ting of an outpatient clinic. Additionally, the overall per-
centage of missing item responses across the PedsQL
scales was low, indicating that children and their parents
were able to provide good data regarding the child’s
HRQOL. However, our results showed that there were
several items, i.e. ‘w o r r ya b o u ts i d ee f f e c tf r o mm e d i c a l
treatment’ and ‘it is had for me to ask the doctors and
nurses questions’, had a high missing rate. We found
that the percentage of missing values was primarily
from the 2-7 years old children. The reason may be that
some parents regarded their children as too young to
understand the questions, or some children aged 5-7
years had difficult to understand these questions, since
not all of them attend kindergarten or school. This find-
ing is comparable with previous reports of the PedsQL
Cancer Module [9], and also in yline with other PedsQL
disease-specific modules [38]. This indicated that some
modifications for the items of these subscales in Toddler
and Young Child version scale were necessary.
No (for Generic Core Scales) or minimal (for the Can-
cer Module) floor effects and more accentuated ceiling
effects for both scales means that distinction by Chinese
Table 8 Intercorrelations among PedsQL Scales and correlation between scores of the child and parent
Tot PH Psy Em Soc Sch P N PA TA W CP A C
Total Score (Tot) 0.493** 0.826** 0.853** 0.818** 0.744** 0.620** 0.476** 0.428** 0.434** 0.380** 0.395** 0.336** 0.304** 0.318**
Physical
functioning (Ph)
0.878** 0.501** 0.591** 0.506** 0.530** 0.486** 0.429** 0.278** 0.316** 0.280** 0.303** 0.245** 0.266** 0.271**
Psychosocial
functioning (Psy)
0.905** 0.585** 0.336** 0.647** 0.631** 0.677** 0.298** 0.322** 0.303** 0.254** 0.370** 0.333** 0.395** 0.257**
Emotional
functioning (Em)
0.860** 0.494** 0.848** 0.327** 0.507** 0.293** 0.231** 0.210** 0.287** 0.224** 0.266** 0.205** 0.239** 0.194*
Social
functioning (Soc)
0.798** 0.535** 0.869** 0.605** 0.359* 0.413** 0.203** 0.136 0.206** 0.264** 0.277** 0.248** 0.233** 0.220**
School
functioning (Sch)
0.729** 0.497** 0.785** 0.375** 0.523** 0.305** 0.356** 0.229** 0.274** 0.297** 0.283** 0.394** 0.195** 0.118
Pain and hurt (P) 0.513** 0.447** 0.461** 0.413** 0.386** 0.342** 0.442** 0.228** 0.297** 0.273** 0.465** 0.305** 0.341** 0.282**
Nausea (N) 0.479** 0.302** 0.337** 0.314** 0.291** 0.292** 0.220** 0.406** 0.235* 0.365** 0.353** 0.238* 0.174* 0.120
Procedural
anxiety (PA)
0.365** 0.278** 0.285** 0.290** 0.272** 0.228** 0252** 0.032 0.349** 0.483** 0.377** 0.174* 0.319** 0.230**
Treatment
anxiety (TA)
0.326** 0.298** 0.382** 0.324** 0.273** 0.204** 0.189* 0.239** 0.434** 0.420* 0.329** 0.341** 0.260** 0.285**
Worry (W) 0.396** 0.237** 0.410** 0.228** 0.239** 0.210** 0.281** 0.281* 0.203** 0.371** 0.354** 0.214** 0.357** 0.219**
Cognitive
problems CP)
0.348** 0.365** 0.376** 0.253** 0.327** 0.424** 0.086 0.139 0.251** 0.349** 0.311** 0.308* 0.398** 0.276**
Appearance (A) 0.315** 0.249** 0.329** 0.295** 0.285** 0.219** 0.253** 0.182* 0.184* 0.335** 0.274** 0.388** 0.322** 0.199**
Communication
(C)
0.354** 0.213** 0.311** 0.291** 0.271** 0.231** 0.270** 0.118 0.321** 0.293** 0.042 0.251** 0.267** 0.318**
Note: scores obtained by child above the diagonal; scores obtained by parent below the diagonal; correlation between scores of the child and parent on the
diagonal. Correlation values between the PedsQL 4.0 Generic Core Scales Total Score with the PedsQL 3.0 Cancer Module Scales are set in boldface. Correlation
values between the scores of child and parent are underlined. All correlations present significance levels when *p < 0.05 and **p < 0.01 (2-tailed).
Table 7 PedsQL 3.0 Cancer Module factor loadings for child self- and parent proxy-report in children with cancer
(Continued)
.024 .181 .193 .175 .551 -.148 .046
C3 .010 -.005 .281 .098 .048 .035 -.188 .742
.113 -.144 .110 .040 .743 .105 .061
Eigenvalue 6.548 4.303 3.635 2.319 2.074 1.771 1.34 1.096
8.682 5.225 3.725 2.756 2.142 1.843 1.447
Percent Variance 24.253 13.936 9.462 7.587 7.182 6.56 4.962 4.057
32.157 15.647 1.091 8.613 8.081 6.715 5.246
Note: Bold values indicate the largest factor loading for each item.
In each cell, child self-report loading are shown above and the parent proxy-report loading are shown below in italics.
Extraction Method: Principle Component Analysis. Rotation Method: Oblimin with Kaiser Normalization. Total Variance Explained for child self-report: 78.0%; for
Parent Proxy-report: 86.6%.
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Page 10 of 13mandarin version of the PedsQL 4.0 Generic Core Scale
and 3.0 Cancer Module between children who do extre-
mely well or just well is less than excellent [39]. On the
other hand, this finding support the opinion that the
PedsQL scaling range is acceptable for use in patients
experiencing greater health-related problems, which is
the area of most concern in research with severe or
chronic illness [40,41].
For internal consistency, both the PedsQL 4.0 Generic
Core Scales and 3.0 Cancer Module reliabilities
approached or exceeded the alpha coefficient standard
of 0.7 for most scales. The PedsQL 4.0 Generic Core
Scales Total Score for parent proxy-report exceeded an
alpha of 0.90, recommended for individual patient analy-
sis, making the Total Scale score suitable as a summary
score for the primary analysis of HRQOL outcome in
clinical trials and other group comparisons [42]. The
total score of the School Functioning, Pain and hurt,
Perceived physical appearance, and Communication sub-
scales for child self-report did not approach or exceed
0.70. These findings are consistent with reliability esti-
mates seen in the original English version and the Ger-
man Version [9,19]. This low internal consistency may
be related to the small number of items that compose
the subscales and the low level of schooling in the sam-
ple. Although Cronbach’s alpha represents the lower
bound of the reliability of a measurement instrument,
and is a conservative estimate of actual reliability [43],
scale that did not meet the 0.70 standard should be
used only for descriptive analyses.
It is recommended that the interval between measure-
ments must be long enough to reduce the effects of
memory and short enough to diminish the likelihood of
systemic alterations. Previous studies found that a per-
iod of 1 to 4 weeks is considered adequate [44,45]. In
this study, we used a 1-3 weeks interval. Meanwhile,
patients were selected who were considered to be stable
and were not expected to change before completing the
questionnaires for the second time. All scales for both
the child self- and parent proxy-reports showed good to
excellent reliability, indicating that the Chinese man-
darin version of PedsQL 4.0 Generic Core Scale and
Cancer Module are stable over time.
As can be expected, the PedsQL 4.0 Generic Core
Scales indicated better HRQOL in children of the gen-
eral population than in children with caner on all scales,
which support the construct validity of the translated
instrument. Additionally, we found that in child self-
and parent proxy-report, physical health subscale scores
and some psychosocial health subscale scores in chil-
dren off-treatment over 12 months were significantly
higher than children on-treatment in the two instru-
ments. This result was similar to another study assessing
HRQOL scores between children on-treatment and
those who were off-treatment [33]. Meanwhile, we
found that many psychosocial health subscale scores
were not significant improved among children who had
been treatment over 12 months. This finding is also in
line with studies of HRQOL in children with cancer
[19,20,33]. It would seem to reflect the long-term bur-
den of psychosocial trials which individuals face as they
grow older: they may be afraid, often on an unconscious
level, that the disease will recur, they may experience a
setback resulting from the stresses during treatment or
they can be confronted with new problems evolving
from the illness or long-term side effects of treatment
[46]. We, like others, believe that psychosocial support
remains important long after treatment has completed,
and even when the physical health appears well [21,47].
The results of the factor analysis in general support
the hypothesized factor structure of the PedsQL. For the
PedsQL 4.0 Generic Core Scales, all items split into two
different factors. The results do not resemble Varni’s
five factor structure in the original PedSQL version [41].
In their study, Emotional Functioning items in both
child self- and parent reports do not split into two dif-
ferent factors. But the findings of factor analysis may be
sample-specific, other studies showed different results
too [27,48], this is why the factor structure should be
reinvestigated in clinical samples. For the PedsQL Can-
cer Module, exploratory factor analysis identified 8 fac-
tors for child self-reports, replicating those of the
original theoretical dimensions. In parent proxy-reports,
those items of the Procedural anxiety and Treatment
anxiety subscales of the original theoretical dimension
loaded on the same factor, reducing the number of fac-
tors to 7. In mainland China, parents generally believe
that the fear of injection, surgery or other invasive treat-
ments is the main reason why their children try to avoid
going to the hospital [49], so that their worry about
treatment may linked to the ‘Procedural anxiety’ factor.
Consistent with the conceptualization of disease-spe-
cific symptoms as causal indicators of generic HRQOL,
the intercorrelations between the PedsQL 4.0 Generic
Core Scales total score and PedsQL 3.0 Cancer Module
were in medium to large range, supporting construct
validity. Regarding the agreement between child self-
and parent proxy-reports, our data showed moderate
to good agreement both for the Generic Core Scales
and the Cancer Module. Finding higher correlations
for the observable parameters in general, like the Phy-
sical Functioning Scale in the Generic Core Scale and
Pain and hurt, Nausea, and Treatment anxiety in the
Cancer Module. This finding is consistent with that of
previous studies [33,38]. Although child self-reports is
critical, perspectives of parents also are important. In
clinical practice, there may be circumstances when the
child is too young, or too ill too complete an
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Page 11 of 13instrument, and parent proxy-report may be needed in
such cases. Additionally, it is typically parents’ percep-
tions of their children’s HRQOL and symptoms that
influences health care utilization. Therefore, in cases in
which pediatric patients are not able to provide self-
report, reliable and valid parent proxy-report instru-
ment are needed [50].
This study has several inherent limitations. One lim-
itation of the study was that the study sample was
entirely composed of patients seeking medical evaluation
or treatment for cancer and cannot be considered repre-
sentative of the general population of pediatric oncology
patients. In mainland China, many children with cancer
have refused or abandoned treatment for financial rea-
sons, which is unknown in developed countries and
regions [51]. Information about the HRQOL in these
patients is still unknown. Second, all the subjects in this
study were recruited in two of the largest cities (Shang-
hai and Chongqing) in China. The majority of our
patients came from urban areas instead of rural areas.
In fact, more than half of China’s population now lives
in rural areas where only a few children under 14 years
of age who have acute leukemia receive protocol based
therapy [23]. Therefore, further studies conducted in
rural areas are suggested. Third, information on partici-
pants’ socioeconomic status was not available. Questions
still exist as to whether socioeconomic status is asso-
ciated with HRQOL in children with cancer in our
society [52].
On the other hand, the information from standardized
questionnaires provided a wealth of information about
the physical and psychosocial status of children with
cancer living in mainland China. Moreover, we com-
pared the patients with normal children matched for sex
and age, and all subjects were recruited from the same
health care catchment areas and assessment were car-
ried out in closely related time periods in both groups.
Therefore, the study of these children could provide a
more accurate picture of pediatric cancer patients refer-
ring to clinical practices, and provide relevant clues for
future interventions that promote care and support of
children with cancer.
Conclusion
In summary, our results generally support the feasibil-
ity, reliability and validity of the Chinese mandarin ver-
sion of PedsQL 4.0 Generic Core Scales and the
Cancer Module. Further studies should focus on test-
ing responsiveness of the Chinese mandarin version
scales in longitudinal studies and in other areas, parti-
cularly in rural areas. Studies measuring HRQOL in
children who have refused or abandoned treatment are
also warranted.
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